Powered by

Weekly: Advanced Proteome Therapeutics jumps 9.1% on low volume March 03, 2017 17:00 EST

Mar 3, 2017 - News Bites Canadian Markets


Advanced Proteome Therapeutics Corporation (TSXV:APC), Canada's 48th largest Biotechnology company by market cap, has climbed 0.50c (or 9.1%) in the past week to close at 6.0c. Compared with the S&P/TSX 60 Index which rose 6.8 points (or 0.8%) in the week, this represented a relative price increase of 8.3%. The volume was 0.1 times average trading per week of 300,070 shares. In the past week the market cap has risen CAD0.6 million.


Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox